Description
+ Include: 10 videos + 10 audios, size: 2.1 GB
+ Target Audience: medical oncologists, hematologist-oncologists, surgeons, radiation oncologists, hospitalists
+ Sample video: contact me for sample video
+ Information:
A focused, clinically oriented update across solid tumors and hematologic malignancies. Expert, case-based lectures convert new evidence and guidelines into clear diagnostic pathways, treatment algorithms, and toxicity-management plans you can put to work immediately in clinic, infusion, and inpatient settings.
What You Will Learn
-
How to incorporate current screening, staging, and biomarker guidance into everyday decisions
-
Practical selection and sequencing of chemotherapy, targeted agents, and immunotherapies
-
Recognition and management of immune-related and targeted-therapy adverse events
-
Multidisciplinary strategies for supportive care, survivorship, and palliative integration
-
Communication pearls for shared decision-making and goal-concordant care
Event Details
-
Format: Live, case-based lectures with panel Q&A and concise take-home checklists
-
Structure: Disease-site blocks plus cross-cutting sessions on genomics, toxicity, and supportive care
-
Access: Designed for rapid implementation in community and academic practice
Who Should Attend
Medical oncologists, hematologist-oncologists, surgeons, radiation oncologists, hospitalists, advanced practice providers, oncology pharmacists, nurses, and fellows/trainees seeking a high-yield, practice-ready update.
Why Attend
-
Translate complex trials and guidelines into simple, usable algorithms
-
Update diagnostic and therapeutic strategies across high-prevalence cancers
-
Improve safety, efficiency, and patient experience with ready-to-use tools and checklists
+ Topics:
Reviews
There are no reviews yet.